Metformin regulates GBM cell lines through the circadian gene PER2 and the SIRT2/G6PD signaling pathway in a PER2-dependent manner, as well as through synergies with the radiotherapy sensitivity of glioma cells. Here, SIRT2 is linked to glioblastoma.